Phibro Operating Income from 2010 to 2026

PAHC Stock

USD 53.07 3.07 6.14%

Phibro Animal's Operating Income is increasing over the years with slightly volatile fluctuation. Overall, Operating Income is expected to go to about 133.4 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Phibro Animal Health generates from its operations. View All Fundamentals

Operating Income

First Reported

2000-03-31

Previous Quarter

47.9 M

Current Value

50.3 M

Quarterly Volatility

11.5 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Phibro Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phibro Animal's main balance sheet or income statement drivers, such as Depreciation And Amortization of 55.1 M, Interest Expense of 18.4 M or Selling General Administrative of 349.5 M, as well as many indicators such as Price To Sales Ratio of 0.87, Dividend Yield of 0.0272 or PTB Ratio of 3.19. Phibro financial statements analysis is a perfect complement when working with Phibro Animal Valuation or Volatility modules.

Build AI portfolio with Phibro Stock

Check out the analysis of Phibro Animal Correlation against competitors.

Analyzing Phibro Animal's Operating Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Income has evolved provides context for assessing Phibro Animal's current valuation and future prospects.

Latest Phibro Animal's Operating Income Growth Pattern

Below is the plot of the Operating Income of Phibro Animal Health over the last few years. Operating Income is the amount of profit realized from Phibro Animal Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Phibro Animal Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Phibro Animal's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phibro Animal's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Phibro Operating Income Regression Statistics

	Arithmetic Mean	79,301,249
	Geometric Mean	72,659,300
	Coefficient Of Variation	36.76
	Mean Deviation	21,875,940
	Median	74,868,000
	Standard Deviation	29,152,630
	Sample Variance	849.9T
	Range	117.7M
	R-Value	0.68
	Mean Square Error	490.2T
	R-Squared	0.46
	Significance	0
	Slope	3,912,361
	Total Sum of Squares	13598T

Phibro Operating Income History

	2026	133.4 M
	2025	127 M
	2024	110.5 M
	2023	53.3 M
	2022	71.8 M
	2021	79 M
	2020	74.9 M

Other Fundumenentals of Phibro Animal Health

Non Operating Income Net Other

Phibro Animal Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.85	0.97	0.86	0.95	0.86	0.99	0.97	1.0	0.7	0.24	-0.24	0.7	0.92	0.88	-0.58	0.2	0.14	-0.55	0.67	0.89	0.82	0.87	0.88	-0.72
Total Stockholder Equity	0.85		0.7	0.98	0.69	0.58	0.84	0.7	0.84	0.8	0.5	-0.53	0.78	0.93	0.96	-0.46	0.51	0.3	-0.77	0.62	0.89	0.93	0.75	0.77	-0.46
Net Debt	0.97	0.7		0.72	0.97	0.92	0.95	0.99	0.96	0.6	0.08	-0.11	0.6	0.83	0.75	-0.6	0.05	0.02	-0.37	0.66	0.8	0.68	0.86	0.85	-0.76
Retained Earnings	0.86	0.98	0.72		0.69	0.63	0.83	0.71	0.84	0.85	0.46	-0.5	0.78	0.94	0.96	-0.48	0.52	0.23	-0.72	0.68	0.91	0.92	0.77	0.79	-0.46
Accounts Payable	0.95	0.69	0.97	0.69		0.87	0.97	0.98	0.96	0.54	0.02	-0.13	0.53	0.78	0.74	-0.58	-0.05	0.08	-0.38	0.57	0.79	0.65	0.83	0.83	-0.78
Long Term Debt	0.86	0.58	0.92	0.63	0.87		0.82	0.91	0.86	0.63	-0.05	0.0	0.57	0.77	0.64	-0.56	0.06	-0.26	-0.09	0.74	0.74	0.55	0.82	0.81	-0.67
Net Receivables	0.99	0.84	0.95	0.83	0.97	0.82		0.96	0.99	0.64	0.14	-0.3	0.62	0.86	0.87	-0.58	0.11	0.14	-0.51	0.58	0.87	0.78	0.85	0.86	-0.76
Total Liab	0.97	0.7	0.99	0.71	0.98	0.91	0.96		0.97	0.58	0.09	-0.08	0.59	0.83	0.76	-0.58	0.03	0.05	-0.39	0.63	0.8	0.69	0.84	0.84	-0.77
Total Current Assets	1.0	0.84	0.96	0.84	0.96	0.86	0.99	0.97		0.7	0.21	-0.21	0.69	0.91	0.89	-0.59	0.2	0.14	-0.53	0.66	0.89	0.81	0.87	0.88	-0.72
Short Term Debt	0.7	0.8	0.6	0.85	0.54	0.63	0.64	0.58	0.7		0.31	-0.35	0.84	0.83	0.81	-0.55	0.61	0.05	-0.49	0.83	0.81	0.8	0.78	0.79	-0.23
Intangible Assets	0.24	0.5	0.08	0.46	0.02	-0.05	0.14	0.09	0.21	0.31		-0.1	0.55	0.5	0.41	0.08	0.62	0.39	-0.75	0.28	0.37	0.6	0.12	0.13	0.14
Common Stock	-0.24	-0.53	-0.11	-0.5	-0.13	0.0	-0.3	-0.08	-0.21	-0.35	-0.1		-0.17	-0.31	-0.34	0.13	-0.17	-0.26	0.4	-0.17	-0.32	-0.35	-0.23	-0.24	0.21
Property Plant Equipment	0.7	0.78	0.6	0.78	0.53	0.57	0.62	0.59	0.69	0.84	0.55	-0.17		0.83	0.78	-0.36	0.56	0.16	-0.62	0.86	0.82	0.87	0.83	0.83	-0.08
Good Will	0.92	0.93	0.83	0.94	0.78	0.77	0.86	0.83	0.91	0.83	0.5	-0.31	0.83		0.91	-0.48	0.49	0.18	-0.66	0.79	0.92	0.89	0.81	0.82	-0.53
Net Tangible Assets	0.88	0.96	0.75	0.96	0.74	0.64	0.87	0.76	0.89	0.81	0.41	-0.34	0.78	0.91		-0.53	0.48	0.26	-0.7	0.61	0.91	0.92	0.78	0.81	-0.48
Current Deferred Revenue	-0.58	-0.46	-0.6	-0.48	-0.58	-0.56	-0.58	-0.58	-0.59	-0.55	0.08	0.13	-0.36	-0.48	-0.53		-0.07	0.02	0.16	-0.47	-0.45	-0.42	-0.6	-0.61	0.37
Short Term Investments	0.2	0.51	0.05	0.52	-0.05	0.06	0.11	0.03	0.2	0.61	0.62	-0.17	0.56	0.49	0.48	-0.07		0.16	-0.49	0.36	0.46	0.52	0.16	0.18	0.14
Deferred Long Term Liab	0.14	0.3	0.02	0.23	0.08	-0.26	0.14	0.05	0.14	0.05	0.39	-0.26	0.16	0.18	0.26	0.02	0.16		-0.73	-0.02	0.13	0.22	0.04	0.05	0.0
Short Long Term Debt	-0.55	-0.77	-0.37	-0.72	-0.38	-0.09	-0.51	-0.39	-0.53	-0.49	-0.75	0.4	-0.62	-0.66	-0.7	0.16	-0.49	-0.73		-0.34	-0.58	-0.78	-0.41	-0.43	0.16
Long Term Debt Total	0.67	0.62	0.66	0.68	0.57	0.74	0.58	0.63	0.66	0.83	0.28	-0.17	0.86	0.79	0.61	-0.47	0.36	-0.02	-0.34		0.73	0.66	0.84	0.83	-0.19
Capital Surpluse	0.89	0.89	0.8	0.91	0.79	0.74	0.87	0.8	0.89	0.81	0.37	-0.32	0.82	0.92	0.91	-0.45	0.46	0.13	-0.58	0.73		0.87	0.86	0.87	-0.55
Long Term Investments	0.82	0.93	0.68	0.92	0.65	0.55	0.78	0.69	0.81	0.8	0.6	-0.35	0.87	0.89	0.92	-0.42	0.52	0.22	-0.78	0.66	0.87		0.77	0.79	-0.34
Net Invested Capital	0.87	0.75	0.86	0.77	0.83	0.82	0.85	0.84	0.87	0.78	0.12	-0.23	0.83	0.81	0.78	-0.6	0.16	0.04	-0.41	0.84	0.86	0.77		1.0	-0.42
Net Working Capital	0.88	0.77	0.85	0.79	0.83	0.81	0.86	0.84	0.88	0.79	0.13	-0.24	0.83	0.82	0.81	-0.61	0.18	0.05	-0.43	0.83	0.87	0.79	1.0		-0.42
Capital Stock	-0.72	-0.46	-0.76	-0.46	-0.78	-0.67	-0.76	-0.77	-0.72	-0.23	0.14	0.21	-0.08	-0.53	-0.48	0.37	0.14	0.0	0.16	-0.19	-0.55	-0.34	-0.42	-0.42

Click cells to compare fundamentals

About Phibro Animal Financial Statements

Phibro Animal stakeholders use historical fundamental indicators, such as Phibro Animal's Operating Income, to determine how well the company is positioned to perform in the future. Although Phibro Animal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Phibro Animal's assets and liabilities are reflected in the revenues and expenses on Phibro Animal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Phibro Animal Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	127 M	133.4 M
Non Operating Income Net Other	-2.8 M	-2.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Phibro Animal Correlation against competitors.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Will Pharmaceuticals sector continue expanding? Could Phibro diversify its offerings? Factors like these will boost the valuation of Phibro Animal. Anticipated expansion of Phibro directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phibro Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

7.52

Dividend Share

0.48

Earnings Share

2.26

Revenue Per Share

36.129

Quarterly Revenue Growth

0.209

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

It's important to distinguish between Phibro Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phibro Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Phibro Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Phibro Operating Income from 2010 to 2026

Latest Phibro Animal's Operating Income Growth Pattern

Phibro Operating Income Regression Statistics

Phibro Operating Income History

Other Fundumenentals of Phibro Animal Health

Phibro Animal Operating Income component correlations

About Phibro Animal Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY